CTRI/2017/06/008750CompletedPhase 1
A Pharmacotherapeutical study of two source plants of Shalaparni - Desmodium gangeticum DC. and Flemingia strobilifera (L.)W.T. Aiton in Vatarakta
Institute for Post Graduate Teaching and Research in Ayurveda0 sites62 target enrollmentStarted: TBDLast updated:
Trial Snapshot
- Phase
- Phase 1
- Status
- Completed
- Sponsor
- Enrollment
- 62
Study Overview
Brief Summary
No summary available.
Study Design
- Study Type
- Interventional
Eligibility Criteria
Inclusion Criteria
- •Patients presenting with classical signs and symptoms of purvarupa early symptoms and rupa symptoms of Vatarakta gout
- •Patients having classical signs and symtoms without sandhivaikalya joint deformity
Exclusion Criteria
- •Patients below 18 and above 70 years of age
- •Patients having sandhivaikalya joint deformity and of Gambhira Vatarakta deep seated gout
- •Patients suffering from any systemic diseases like Diabetes Hypertension Cardiac Anomaly Chronic renal failure Liver cirrhosis
- •Pregnant and lactating mother
Investigators
Similar Trials
Completed
Phase 1
A Clinical study of two source plants of Shalparni in VataraktaCTRI/2015/07/006004Institute for Post Graduate Teaching and Research in Ayurveda60
Completed
Not Applicable
Efficacy test of plant extracts for physical effect.Healthy adultsJPRN-UMIN000038318Kao Corporation15
Completed
Phase 3
Comparison of the effect of botanical extract mouthwashes of meswak/aloe vera and chlorhexidine on prevention of ventilator-associated pneumoniaIRCT20161014030294N4Arak University of Medical Sciences70
Recruiting
Not Applicable
Study of the combination of amukkirai chooranam with thalangai ennai and vellarugu chooranam with thalangai ennai in the treatment of knee osteoarthritisKnee OsteoarthritisSLCTR/2012/009HETC Project, Ministry of Higher Education, Sri Lanka.300
Completed
Not Applicable
a study to know if the leaf extracts could prolong the life of a filling in the patients mouth.CTRI/2021/04/033069avanya Anumula50
